Related Experiment Videos
Levorphanol-sensitive [3H]naloxone binding in developing brainstem following prenatal morphine exposure
Neuroscience Letters
|February 21, 1983
Summary
Maternal morphine exposure during gestation reduced brainstem opioid receptor levels in fetal rats. However, these receptor levels normalized by postnatal day 60, indicating developmental resilience to prenatal opioid exposure.
Area of Science:
- Neuroscience
- Pharmacology
- Developmental Biology
Background:
- Prenatal exposure to opioids can impact fetal development.
- Opioid receptors in the brainstem play a crucial role in regulating vital functions.
- Understanding the long-term effects of maternal opioid use on offspring is critical.
Purpose of the Study:
- To investigate the effects of maternal morphine exposure on levorphanol-sensitive [3H]naloxone binding in rat brainstems.
- To assess changes in opioid receptor concentration and affinity during fetal development and early postnatal life.
Main Methods:
- Rat dams were injected with morphine or saline during the last half of gestation.
- Brainstems from fetuses and postnatal offspring were analyzed for [3H]naloxone binding.
- Receptor concentration and binding affinity were measured at different developmental time points.
Main Results:
- Maternal morphine exposure significantly decreased brainstem opioid receptor concentration in fetuses.
- Binding affinity remained unchanged in fetuses exposed to morphine.
- By postnatal day 60, both receptor concentration and affinity in offspring of morphine-treated dams were comparable to controls.
Conclusions:
- Prenatal morphine exposure transiently alters brainstem opioid receptor levels in developing rats.
- The developing brain exhibits compensatory mechanisms that restore opioid receptor levels postnatally.
- These findings suggest a potential for recovery from developmental effects of in utero opioid exposure.